Meridian Wealth Management, LLC Amicus Therapeutics, Inc. Transaction History

Meridian Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$10.96 - $14.4 $171,534 - $225,374	-15,651 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $75,300 - $104,400	-7,500 Reduced 32.4%	15,651 $2.13 Million
Q4 2018 Feb 05, 2019	BUY	$8.38 - $13.44 $68,305 - $109,549	8,151 Added 54.34%	23,151 $222,000
Q3 2018 Oct 19, 2018	BUY	$11.6 - $16.54 $174,000 - $248,100	15,000 New	15,000 $181,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Management, LLC with notifications on news.